Table 3. Summary of articles used.
SLE: systemic lupus erythematosus
| Reference number | Author, year, and type | Purpose | Results |
| [13] | Catanzaro et al., 2018, review article | Study the immune modulatory role of curcumin | Active components of medicinal plants can be used for treating several inflammatory autoimmune diseases in the long run |
| [5] | Pan et al., 2020, literature review | Explain the pathogenesis of SLE, and decide the treatment options based on the same | Understanding the mechanism of SLE evolution helps decide the target for drug action |
| [1] | Beccastrini et al., 2013, review article | Understand the immunopathogenesis of lupus, and understand the treatment options | Treatment can be tailored to various subsets of patients, depending on their preferences and response to treatment |
| [8] | Giraldo et al., 2012, review article | Analyze the mechanism of lupus and the molecules used for its management | Several alternative newer drugs can be used for patient management |
| [2] | Rivas-Larrauri and Yamazaki-Nakashimada, 2016, review article | Study various genetic defects associated with SLE to individualize treatment | Many genetic factors play a role in SLE development |
| [14] | Connolly and Hakonarson, 2012, literature review | Study genomic approaches toward SLE | Genetics can play a significant role in the development of lupus |
| [15] | Nagafuchi et al., 2019, review article | Discuss immune profiling of lupus and its role in medical management | Biomarkers will help guide the treatment and assessment of improvement |
| [3] | Tsang-A-Sjoe and Bultink, 2021, literature review | Compare newer drugs to decide on lupus treatment options | Newer treatment options are required due to toxic reactions of currently approved drugs |